drugset / Trial / NCT00840879

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

NCT00840879

Phase 1 Completed 28 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of meloxicam from a test formulation Meloxicam 15 mg Tablets versus the reference Mobic® 15 mg Tablets under fed conditions.

Timeline

Start
2004-02
Primary completion
2004-02
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 15 mg

Indications

No indication recorded.